LeonaBio, Inc. (LONA): Total Assets
$92.15M
As of 2025-12-31
$56.89M
As of 2026-06-30
-29.1%
3-year compound annual growth
-19.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $92.15M | +56.8% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $58.78M | -63.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $160.25M | -37.9% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $258.15M | -22.2% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $332.01M | +18.8% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $279.56M | n/m | 2022-03-28, Balance as of period end |
| 2019-12-31 | $2.19M | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| LeonaBio, Inc. (LONA) | 2025-12-31 | $92.15M | +56.8% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $93.00M | -4.0% |
| IRulya Therapeutics Inc. (IRLA) | 2025-12-31 | $93.52M | -18.3% |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | $88.53M | +26.3% |
| Surrozen, Inc. (SRZN) | 2025-12-31 | $98.73M | +103.7% |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $82.35M | +12.2% |
| Anavex Life Sciences Corp. (AVXL) | 2025-09-30 | $103.81M | -23.4% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $79.73M | +57.1% |
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | $76.88M | -11.1% |
Compare LONA, ATYR, IRLA, ALGS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗